Karolinska Development :: Press Releases

2018-04-16

Karolinska Development's portfolio company Aprea presents initial results from the ongoing phase Ib/II study with APR-246 and azacitidine for the treatment of Mutant Myelodysplastic Syndromes
2018-04-13

Karolinska Development sells remaining shares in BioArctic
2018-03-21

Karolinska Development Annual Report 2017 published
2018-03-21

Notice of Annual General Meeting in Karolinska Development AB (publ)
2018-02-15

Karolinska Development: Q4 and 2017 Year-End Report - January-December